Revvity, Inc. (RVTY) Stock Score, Valuation & Financial Research

Revvity, Inc. is in the Healthcare sector and Medical - Diagnostics & Research industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 27/100.

Quick answer for RVTY

Revvity, Inc. currently has a Wall Street Score of 27/100. The stored market price is $124.31. Its financial score is 12/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.

What Revvity, Inc. does

Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves t

RVTY financial snapshot

Wall Street Score:
27/100
Current price:
$124.31
Market capitalization:
$13.87B
Revenue:
$2.90B
Net income:
$241.0M
Free cash flow:
$508.3M
Cash:
$860.3M
Total debt:
$3.35B
EPS:
2.08
P/E ratio:
59.8x
Financial score:
12/100
Valuation score:
0/100
Revenue score:
11/100

What stands out

  • Reported year-over-year revenue growth is +0.0%.
  • Free cash flow is $508.3M, showing positive cash generation.
  • The balance sheet shows $860.3M of cash versus $3.35B of total debt, so leverage deserves attention.

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 12/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-07-24.

How to research RVTY

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.